1-[(2-chlorophenyl)methyl]-N-(cyclopropylmethyl)-N-(4-methylphenyl)pyrrolidine-3-carboxamide;N-(cyclopropylmethyl)-4-(3,5-dichloro-2-pyridinyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide;N-(cyclopropylmethyl)-4-(2-methoxyphenyl)-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carboxamide;N-(cyclopropylmethyl)-N-(4-methylphenyl)-1-[[2-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carboxamide;6-methoxy-2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzothiazole;2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzoxazole

C128H144Cl3F6N17O9S — CID 158310215

IUPAC1-[(2-chlorophenyl)methyl]-N-(cyclopropylmethyl)-N-(4-methylphenyl)pyrrolidine-3-carboxamide;N-(cyclopropylmethyl)-4-(3,5-dichloro-2-pyridinyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide;N-(cyclopropylmethyl)-4-(2-methoxyphenyl)-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carboxamide;N-(cyclopropylmethyl)-N-(4-methylphenyl)-1-[[2-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carboxamide;6-methoxy-2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzothiazole;2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzoxazole
SMILESCOc1ccc(N(CC2CC2)C(=O)N2CCN(c3ncc(Cl)cc3Cl)CC2)cc1.COc1ccc2nc(N3CCN(c4ccccc4C)CC3)sc2c1.COc1ccccc1N1CCN(C(=O)N(CC2CC2)c2ccc(OC(F)(F)F)cc2)CC1.Cc1ccc(N(CC2CC2)C(=O)C2CCN(Cc3ccccc3C(F)(F)F)C2)cc1.Cc1ccc(N(CC2CC2)C(=O)C2CCN(Cc3ccccc3Cl)C2)cc1.Cc1ccccc1N1CCN(c2nc3ccccc3o2)CC1
InChIInChI=1S/C24H27F3N2O.C23H27ClN2O.C23H26F3N3O3.C21H24Cl2N4O2.C19H21N3OS.C18H19N3O/c1-17-6-10-21(11-7-17)29(14-18-8-9-18)23(30)20-12-13-28(16-20)15-19-4-2-3-5-22(19)24(25,26)27;1-17-6-10-21(11-7-17)26(14-18-8-9-18)23(27)20-12-13-25(16-20)15-19-4-2-3-5-22(19)24;1-31-21-5-3-2-4-20(21)27-12-14-28(15-13-27)22(30)29(16-17-6-7-17)18-8-10-19(11-9-18)32-23(24,25)26;1-29-18-6-4-17(5-7-18)27(14-15-2-3-15)21(28)26-10-8-25(9-11-26)20-19(23)12-16(22)13-24-20;1-14-5-3-4-6-17(14)21-9-11-22(12-10-21)19-20-16-8-7-15(23-2)13-18(16)24-19;1-14-6-2-4-8-16(14)20-10-12-21(13-11-20)18-19-15-7-3-5-9-17(15)22-18/h2-7,10-11,18,20H,8-9,12-16H2,1H3;2-7,10-11,18,20H,8-9,12-16H2,1H3;2-5,8-11,17H,6-7,12-16H2,1H3;4-7,12-13,15H,2-3,8-11,14H2,1H3;3-8,13H,9-12H2,1-2H3;2-9H,10-13H2,1H3
InChIKeyGNOZUYLYBYXULQ-UHFFFAOYSA-N
MW2317.08 g/mol
LogP26.90
Rot. Bonds28

About 1-[(2-chlorophenyl)methyl]-N-(cyclopropylmethyl)-N-(4-methylphenyl)pyrrolidine-3-carboxamide;N-(cyclopropylmethyl)-4-(3,5-dichloro-2-pyridinyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide;N-(cyclopropylmethyl)-4-(2-methoxyphenyl)-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carboxamide;N-(cyclopropylmethyl)-N-(4-methylphenyl)-1-[[2-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carboxamide;6-methoxy-2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzothiazole;2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzoxazole

1-[(2-chlorophenyl)methyl]-N-(cyclopropylmethyl)-N-(4-methylphenyl)pyrrolidine-3-carboxamide;N-(cyclopropylmethyl)-4-(3,5-dichloro-2-pyridinyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide;N-(cyclopropylmethyl)-4-(2-methoxyphenyl)-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carboxamide;N-(cyclopropylmethyl)-N-(4-methylphenyl)-1-[[2-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carboxamide;6-methoxy-2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzothiazole;2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzoxazole (PubChem CID 158310215) has the molecular formula C128H144Cl3F6N17O9S and a molecular weight of 2317.08 g/mol. Its IUPAC name is 1-[(2-chlorophenyl)methyl]-N-(cyclopropylmethyl)-N-(4-methylphenyl)pyrrolidine-3-carboxamide;N-(cyclopropylmethyl)-4-(3,5-dichloro-2-pyridinyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide;N-(cyclopropylmethyl)-4-(2-methoxyphenyl)-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carboxamide;N-(cyclopropylmethyl)-N-(4-methylphenyl)-1-[[2-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carboxamide;6-methoxy-2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzothiazole;2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzoxazole.

Molecular Properties

Compound Name1-[(2-chlorophenyl)methyl]-N-(cyclopropylmethyl)-N-(4-methylphenyl)pyrrolidine-3-carboxamide;N-(cyclopropylmethyl)-4-(3,5-dichloro-2-pyridinyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide;N-(cyclopropylmethyl)-4-(2-methoxyphenyl)-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carboxamide;N-(cyclopropylmethyl)-N-(4-methylphenyl)-1-[[2-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carboxamide;6-methoxy-2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzothiazole;2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzoxazole
PubChem CID158310215
Molecular FormulaC128H144Cl3F6N17O9S
Molecular Weight2317.08 g/mol
Exact Mass2314.00
IUPAC Name1-[(2-chlorophenyl)methyl]-N-(cyclopropylmethyl)-N-(4-methylphenyl)pyrrolidine-3-carboxamide;N-(cyclopropylmethyl)-4-(3,5-dichloro-2-pyridinyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide;N-(cyclopropylmethyl)-4-(2-methoxyphenyl)-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carboxamide;N-(cyclopropylmethyl)-N-(4-methylphenyl)-1-[[2-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carboxamide;6-methoxy-2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzothiazole;2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzoxazole
SMILESCOc1ccc(N(CC2CC2)C(=O)N2CCN(c3ncc(Cl)cc3Cl)CC2)cc1.COc1ccc2nc(N3CCN(c4ccccc4C)CC3)sc2c1.COc1ccccc1N1CCN(C(=O)N(CC2CC2)c2ccc(OC(F)(F)F)cc2)CC1.Cc1ccc(N(CC2CC2)C(=O)C2CCN(Cc3ccccc3C(F)(F)F)C2)cc1.Cc1ccc(N(CC2CC2)C(=O)C2CCN(Cc3ccccc3Cl)C2)cc1.Cc1ccccc1N1CCN(c2nc3ccccc3o2)CC1
InChIInChI=1S/C24H27F3N2O.C23H27ClN2O.C23H26F3N3O3.C21H24Cl2N4O2.C19H21N3OS.C18H19N3O/c1-17-6-10-21(11-7-17)29(14-18-8-9-18)23(30)20-12-13-28(16-20)15-19-4-2-3-5-22(19)24(25,26)27;1-17-6-10-21(11-7-17)26(14-18-8-9-18)23(27)20-12-13-25(16-20)15-19-4-2-3-5-22(19)24;1-31-21-5-3-2-4-20(21)27-12-14-28(15-13-27)22(30)29(16-17-6-7-17)18-8-10-19(11-9-18)32-23(24,25)26;1-29-18-6-4-17(5-7-18)27(14-15-2-3-15)21(28)26-10-8-25(9-11-26)20-19(23)12-16(22)13-24-20;1-14-5-3-4-6-17(14)21-9-11-22(12-10-21)19-20-16-8-7-15(23-2)13-18(16)24-19;1-14-6-2-4-8-16(14)20-10-12-21(13-11-20)18-19-15-7-3-5-9-17(15)22-18/h2-7,10-11,18,20H,8-9,12-16H2,1H3;2-7,10-11,18,20H,8-9,12-16H2,1H3;2-5,8-11,17H,6-7,12-16H2,1H3;4-7,12-13,15H,2-3,8-11,14H2,1H3;3-8,13H,9-12H2,1-2H3;2-9H,10-13H2,1H3
InChIKeyGNOZUYLYBYXULQ-UHFFFAOYSA-N
XLogP26.90
TPSA202.37 Ų
H-Bond Donors
H-Bond Acceptors21
Rotatable Bonds28
Heavy Atoms164
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002317.08
LogP ≤ 526.90
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1021

Analyze 1-[(2-chlorophenyl)methyl]-N-(cyclopropylmethyl)-N-(4-methylphenyl)pyrrolidine-3-carboxamide;N-(cyclopropylmethyl)-4-(3,5-dichloro-2-pyridinyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide;N-(cyclopropylmethyl)-4-(2-methoxyphenyl)-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carboxamide;N-(cyclopropylmethyl)-N-(4-methylphenyl)-1-[[2-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carboxamide;6-methoxy-2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzothiazole;2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzoxazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-(5-chloro-2-methylphenyl)-N-(cyclopropylmethyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide;1-[(2-chlorophenyl)methyl]-N-(cyclopropylmethyl)-N-(4-methylphenyl)pyrrolidine-3-carboxamide;N-(cyclopropylmethyl)-4-(3,5-dichloro-2-pyridinyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide;N-(cyclopropylmethyl)-4-(2-methoxyphenyl)-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carboxamide;N-(cyclopropylmethyl)-N-(4-methylphenyl)-1-[[2-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carboxamide;2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzoxazole
CID 158069795
1-[1-[3-[4-(1,3-benzothiazol-2-yl)piperidin-1-yl]propyl]-7-chloroindol-3-yl]ethanone;1-[3-[3-[4-(1,3-benzothiazol-2-yl)piperidin-1-yl]propyl]-4-methoxy-3H-inden-1-yl]ethanone;1-[3-[4-(1,3-benzothiazol-2-yl)piperidin-1-yl]propyl]-7-methoxy-N-(2-methylpropyl)indole-3-carboxamide;[1-[3-(4-butylpiperidin-1-yl)propyl]-7-methoxyindol-3-yl]-cyclopropylmethanone;1-[1-[3-[4-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazin-1-yl]propyl]-7-methoxyindol-3-yl]ethanone
CID 158853902
1-[4-(1,3-benzoxazol-2-ylmethyl)piperazin-1-yl]-2-methylpropan-1-one;1-[4-[(5-chloro-1,3-benzothiazol-2-yl)methyl]piperazin-1-yl]-2-methylpropan-1-one;1-[4-[(7-chloro-1,3-benzoxazol-2-yl)methyl]piperazin-1-yl]-2-methylpropan-1-one;N-(5-chloro-2-pyridinyl)-2-[4-(2-methylpropanoyl)piperazin-1-yl]acetamide;N-ethyl-N-(4-fluorophenyl)-2-[4-(2-methylpropanoyl)piperazin-1-yl]acetamide;2-methyl-1-[4-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]piperazin-1-yl]propan-1-one
CID 161373857
1-[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]-2-[4-(dimethylamino)phenyl]ethanone;2-(4-chlorophenyl)-1-[4-(6-methyl-[1,3]oxazolo[4,5-b]pyridin-2-yl)piperazin-1-yl]ethanone;N-(4-cyclopropyl-2-fluorophenyl)-4-(4-fluoro-6-methyl-1,3-benzothiazol-2-yl)piperazine-1-carboxamide;2-[4-(dimethylamino)phenyl]-1-[4-(4-fluoro-1,3-benzothiazol-2-yl)piperazin-1-yl]ethanone;bis(2-[4-(dimethylamino)phenyl]-1-[4-(4-fluoro-6-methyl-1,3-benzothiazol-2-yl)piperazin-1-yl]ethanone);4-(4-fluoro-6-methyl-1,3-benzothiazol-2-yl)-N-(4-propan-2-ylphenyl)piperazine-1-carboxamide
CID 165072411

Frequently Asked Questions

What is the IUPAC name of 1-[(2-chlorophenyl)methyl]-N-(cyclopropylmethyl)-N-(4-methylphenyl)pyrrolidine-3-carboxamide;N-(cyclopropylmethyl)-4-(3,5-dichloro-2-pyridinyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide;N-(cyclopropylmethyl)-4-(2-methoxyphenyl)-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carboxamide;N-(cyclopropylmethyl)-N-(4-methylphenyl)-1-[[2-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carboxamide;6-methoxy-2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzothiazole;2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzoxazole?
The IUPAC name of 1-[(2-chlorophenyl)methyl]-N-(cyclopropylmethyl)-N-(4-methylphenyl)pyrrolidine-3-carboxamide;N-(cyclopropylmethyl)-4-(3,5-dichloro-2-pyridinyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide;N-(cyclopropylmethyl)-4-(2-methoxyphenyl)-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carboxamide;N-(cyclopropylmethyl)-N-(4-methylphenyl)-1-[[2-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carboxamide;6-methoxy-2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzothiazole;2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzoxazole (CID 158310215) is 1-[(2-chlorophenyl)methyl]-N-(cyclopropylmethyl)-N-(4-methylphenyl)pyrrolidine-3-carboxamide;N-(cyclopropylmethyl)-4-(3,5-dichloro-2-pyridinyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide;N-(cyclopropylmethyl)-4-(2-methoxyphenyl)-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carboxamide;N-(cyclopropylmethyl)-N-(4-methylphenyl)-1-[[2-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carboxamide;6-methoxy-2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzothiazole;2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzoxazole.
What is the SMILES notation for 1-[(2-chlorophenyl)methyl]-N-(cyclopropylmethyl)-N-(4-methylphenyl)pyrrolidine-3-carboxamide;N-(cyclopropylmethyl)-4-(3,5-dichloro-2-pyridinyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide;N-(cyclopropylmethyl)-4-(2-methoxyphenyl)-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carboxamide;N-(cyclopropylmethyl)-N-(4-methylphenyl)-1-[[2-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carboxamide;6-methoxy-2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzothiazole;2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzoxazole?
The canonical SMILES for 1-[(2-chlorophenyl)methyl]-N-(cyclopropylmethyl)-N-(4-methylphenyl)pyrrolidine-3-carboxamide;N-(cyclopropylmethyl)-4-(3,5-dichloro-2-pyridinyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide;N-(cyclopropylmethyl)-4-(2-methoxyphenyl)-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carboxamide;N-(cyclopropylmethyl)-N-(4-methylphenyl)-1-[[2-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carboxamide;6-methoxy-2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzothiazole;2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzoxazole is COc1ccc(N(CC2CC2)C(=O)N2CCN(c3ncc(Cl)cc3Cl)CC2)cc1.COc1ccc2nc(N3CCN(c4ccccc4C)CC3)sc2c1.COc1ccccc1N1CCN(C(=O)N(CC2CC2)c2ccc(OC(F)(F)F)cc2)CC1.Cc1ccc(N(CC2CC2)C(=O)C2CCN(Cc3ccccc3C(F)(F)F)C2)cc1.Cc1ccc(N(CC2CC2)C(=O)C2CCN(Cc3ccccc3Cl)C2)cc1.Cc1ccccc1N1CCN(c2nc3ccccc3o2)CC1.
What is the InChIKey of 1-[(2-chlorophenyl)methyl]-N-(cyclopropylmethyl)-N-(4-methylphenyl)pyrrolidine-3-carboxamide;N-(cyclopropylmethyl)-4-(3,5-dichloro-2-pyridinyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide;N-(cyclopropylmethyl)-4-(2-methoxyphenyl)-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carboxamide;N-(cyclopropylmethyl)-N-(4-methylphenyl)-1-[[2-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carboxamide;6-methoxy-2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzothiazole;2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzoxazole?
The InChIKey is GNOZUYLYBYXULQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H27F3N2O.C23H27ClN2O.C23H26F3N3O3.C21H24Cl2N4O2.C19H21N3OS.C18H19N3O/c1-17-6-10-21(11-7-17)29(14-18-8-9-18)23(30)20-12-13-28(16-20)15-19-4-2-3-5-22(19)24(25,26)27;1-17-6-10-21(11-7-17)26(14-18-8-9-18)23(27)20-12-13-25(16-20)15-19-4-2-3-5-22(19)24;1-31-21-5-3-2-4-20(21)27-12-14-28(15-13-27)22(30)29(16-17-6-7-17)18-8-10-19(11-9-18)32-23(24,25)26;1-29-18-6-4-17(5-7-18)27(14-15-2-3-15)21(28)26-10-8-25(9-11-26)20-19(23)12-16(22)13-24-20;1-14-5-3-4-6-17(14)21-9-11-22(12-10-21)19-20-16-8-7-15(23-2)13-18(16)24-19;1-14-6-2-4-8-16(14)20-10-12-21(13-11-20)18-19-15-7-3-5-9-17(15)22-18/h2-7,10-11,18,20H,8-9,12-16H2,1H3;2-7,10-11,18,20H,8-9,12-16H2,1H3;2-5,8-11,17H,6-7,12-16H2,1H3;4-7,12-13,15H,2-3,8-11,14H2,1H3;3-8,13H,9-12H2,1-2H3;2-9H,10-13H2,1H3.
What are the key properties of 1-[(2-chlorophenyl)methyl]-N-(cyclopropylmethyl)-N-(4-methylphenyl)pyrrolidine-3-carboxamide;N-(cyclopropylmethyl)-4-(3,5-dichloro-2-pyridinyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide;N-(cyclopropylmethyl)-4-(2-methoxyphenyl)-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carboxamide;N-(cyclopropylmethyl)-N-(4-methylphenyl)-1-[[2-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carboxamide;6-methoxy-2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzothiazole;2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzoxazole?
1-[(2-chlorophenyl)methyl]-N-(cyclopropylmethyl)-N-(4-methylphenyl)pyrrolidine-3-carboxamide;N-(cyclopropylmethyl)-4-(3,5-dichloro-2-pyridinyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide;N-(cyclopropylmethyl)-4-(2-methoxyphenyl)-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carboxamide;N-(cyclopropylmethyl)-N-(4-methylphenyl)-1-[[2-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carboxamide;6-methoxy-2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzothiazole;2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzoxazole has a molecular weight of 2317.08 g/mol, XLogP of 26.90, 28 rotatable bonds, 0 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[(2-chlorophenyl)methyl]-N-(cyclopropylmethyl)-N-(4-methylphenyl)pyrrolidine-3-carboxamide;N-(cyclopropylmethyl)-4-(3,5-dichloro-2-pyridinyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide;N-(cyclopropylmethyl)-4-(2-methoxyphenyl)-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carboxamide;N-(cyclopropylmethyl)-N-(4-methylphenyl)-1-[[2-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carboxamide;6-methoxy-2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzothiazole;2-[4-(2-methylphenyl)piperazin-1-yl]-1,3-benzoxazole is sourced from PubChem (CID 158310215), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).